Glenmark Introduces Tevimbra in India for Advanced Cancer Care

In a significant milestone for the evolution of cancer care in India, Glenmark Pharmaceuticals announced the launch of Tevimbra (tislelizumab), an innovative immune-oncology drug of the Central Drugs Standard Control Organization (CDSCO)...

FDA Approves Datroway by AstraZeneca, Daiichi Sankyo for Lung Cancer

The U.S. Food and Drug Administration (FDA) approved Datroway (datopotamab deruxtecan-dlnk), an innovative TROP2-directed antibody-drug conjugate by AstraZeneca and Daiichi Sankyo, with accelerated approval. The indication is that this is applic...

Merck's WINREVAIR Shows Positive Phase 3 Results in PAH

Merck, known as MSD outside the U.S. and Canada, has announced positive topline results from its Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk)

PLI Scheme Spurs Growth in High-Precision Medtech Value Chains

India's MedTech ecosystem is getting a massive boost through the Production Linked Incentive (PLI) scheme for medical devices. For Falgun Jani, Business Head, Freudenberg Medical India, the policy thrust towards high-end diagnostic

India Unleashes Rs. 5,000 Cr Innovation Fund to Lead Global Creation

India's pharma and MedTech industries await the change with the launch of the Rs. 5,000-crore Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.

Novo Nordisk Plans Nationwide Launch of Wegovy in Indian Market

Danish pharmaceutical leader Novo Nordisk is targeting $1 billion (Rs 8,600 crore) in sales in India with its highly successful weight-loss medication Wegovy (semaglutide) within the next five to seven years. To achieve this goal, ET has learned that

Needle-free HIV vaccine study begins with Immuno Cure, PharmaJet

Immuno Cure BioTech, located in Hong Kong Science Park, has formed a partnership with PharmaJet to assess the safety and immunogenicity of ICVAX, Immuno Cure's HIV therapeutic DNA

ICMR-NIIH Develops World's First Rapid Test for Haemophilia A and VWD

The Indian Council of Medical Research’s National Institute of Immunohaematology (ICMR-NIIH) has developed the world’s first simple...

Atogepant Preferred Over Topiramate in New Migraine Study

When comparing the tolerability, safety, and effectiveness of atogepant to the highest tolerated dose of topiramate in adult patients with a history of four or more migraine days per month.

Amazon Rolls Out Home Diagnostic Services in 6 Major Indian Cities

Amazon India expanded its healthcare services further with the launch of Amazon Diagnostics, an in-home diagnostic testing service to deliver quick, secure, and easy lab testing to the doorsteps of customers.

© 2025 India Pharma Outlook. All Rights Reserved.